News wrap-up: This week’s headlines, plus retired police dog receives life-saving surgery

Article

Check out this week’s headlines

Kathy images/stock.adobe.com

Kathy images/stock.adobe.com

Happy Friday dvm360 readers! We hope you all had a great week and are looking forward to an even greater weekend. Next week, dvm360 will provide you with coverage of the North American Veterinary Community Veterinary Meeting & Expo in Orlando, Florida. Be sure to check back in with us to stay updated!

In the meantime, here is what was popular this week on dvm360.com:

  • Dalan Animal, Inc. received a conditional license from the USDA for a first-in-class vaccine to protect honeybees against American Foulbrood disease caused by Paenibacillus larvae.
  • The American Heartworm Association (AHS) is calling for veterinarians to engage in its 2022 AHS Heart Worm Incidence Survey. The deadline to submit data to the survey is March 15, 2023, and the new 2022 AHS map will be available in April for Heartworm Awareness Month.
  • On this week’s episode of The Vet Blast Podcast, Rachel Venable, DVM, MS, DACVIM (Oncology), offers tips and tricks to help general practitioners understand chemotherapy and the legalities behind it.
  • Thor, a 13-year-old Dutch shepherd and former police narcotics dog, received a lifesaving surgery from the Virginia-Maryland College of Veterinary Medicine’s Veterinary Teaching Hospital after he swallowed a Christmas elf plush toy and a Kong brand plush teddy bear.
  • The Association of Shelter Veterinarians released the second edition of its Guidelines for Standards of Care in Animal Shelters to provide evidence-based support for veterinary professionals caring for animals in fosters, sanctuaries, shelters, rescues, and other population settings.
  • The Louisiana State University School of Veterinary Medicine played a significant role in diagnosing and treating several horses in Louisiana infected with Clostridium botulinum type C, which causes botulism.
  • And more!
Related Videos
© 2024 MJH Life Sciences

All rights reserved.